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Sudden cardiac deathHereditary long QT syndrome (LQTS) is associated with ventricular torsade de pointes tachyarrhythmias and
sudden cardiac death. Mutations in a cardiac voltage-gated potassium channel, KCNQ1, induce the most
frequent variant of LQTS. We identiﬁed a KCNQ1 missense mutation, KCNQ1 S277L, in a patient presenting
with recurrent syncope triggered by emotional stress (QTc=528 ms). This mutation is located in the
conserved S5 transmembrane region of the KCNQ1 channel. Using in vitro electrophysiological testing in the
Xenopus oocyte expression system, the S277L mutation was found to be non-functional and to suppress wild
type currents in dominant-negative fashion in the presence and in the absence of the regulatory ß-subunit,
KCNE1. In addition, expression of S277L and wild type KCNQ1 with KCNE1 resulted in a shift of the voltage-
dependence of activation by−8.7 mV compared to wild type IKs, indicating co-assembly of mutant and wild
type subunits. The electrophysiological phenotype corresponds well with the severe clinical phenotype of the
index patient. However, investigation of family members revealed three patients that exhibit asymptomatic
QT interval prolongation (QTc=493–518 ms). In conclusion, this study emphasizes the value of biophysical
testing to provide mechanistic evidence for pathogenicity of ion channel mutations identiﬁed in LQTS
patients. The inconsistent association of the KCNQ1 S277L mutation with the clinical presentation suggests
that additional genetic, epigenetic, or environmental factors play a role in deﬁning the individual clinical LQTS
phenotype.+49 6221 565514.
e (D. Thomas).
ll rights reserved.© 2011 Elsevier B.V. All rights reserved.1. Introduction
Hereditary long QT syndromes (LQTS) are cardiac repolarization
abnormalities characterized by a prolonged QT interval on the surface
ECG. LQTS are associated with syncope and a high risk of sudden
cardiac death due to ventricular tachyarrhythmias [1]. More than 700
mutations in twelve different genes have been described to date [2].
LQTS1, the most frequent form of LQTS, is associated with KCNQ1
(KvLQT1) gene mutations [3]. Co-expression of the pore-forming α-
subunit KCNQ1 and its regulatory β-subunit KCNE1 (minK) elicits
slowly activating potassium currents, resembling the slow compo-
nent of the cardiac delayed rectiﬁer potassium current IKs [4,5]. IKs
contributes to cardiac repolarization and is a target for class III
antiarrhythmic drugs such as dronedarone [6]. Loss-of-function
mutations in KCNQ1 lead to prolonged cardiac repolarization and
cause congenital long QT syndrome 1 [7–12]. In contrast, KCNQ1
gain-of-function mutations may induce short QT syndrome [13] or
hereditary atrial ﬁbrillation [14].Previous work on genotype–phenotype correlations has indicated
that the individual LQTS genotype inﬂuences the clinical course
[15,16]. Approximately one third of KCNQ1 mutations identiﬁed in
LQTS patients are located in the pore region or in adjacent
transmembrane regions, S5 and S6 [17]. Carriers of these mutations
exhibit a higher risk for cardiac events and tend to be affected at
younger ages compared to patients with mutations in the C-terminal
region [18,19]. Furthermore, Moss et al. [20] revealed that location of
KCNQ1 mutations in the pore and transmembrane regions and
dominant-negative current suppression in vitro may serve as
predictors of severe clinical courses independent of traditional
clinical risk factors, suggesting potential signiﬁcance for therapy
planning in LQTS patients.
In the present study, we analyse biophysical properties of mutant
KCNQ1 S277L potassium channels identiﬁed in a German LQTS family.
This mutation is located in the S5 transmembrane region of the
KCNQ1 channel and causes loss of channel function. However, closely
related family members display phenotypic variability ranging from
asymptomatic QTc prolongation to recurrent ventricular tachycardia
despite harbouring the same mutation associated with a severe
cellular phenotype. We conclude that modifying factors contribute to
the individual clinical phenotype to a larger extent than previously
appreciated.
489P. Aidery et al. / Biochimica et Biophysica Acta 1812 (2011) 488–4942. Materials and methods
2.1. Pedigree and mutation analysis
Clinical evaluation and blood samples are based on an LQTS family
of German origin (Fig. 1A). The index patient (II.4, female) was
brought to our attention after recurrent syncope and aborted sudden
death had occurred during emotional stress. The investigation
conforms to the principles outlined in the Declaration of Helsinki.
Informed consent was obtained for genetic analyses. DNA sequence
analyses were performed by the Center for Human Genetics and
Laboratory Medicine (Martinsried, Germany).2.2. Molecular biology
Complementary DNA encoding human KCNQ1 and human KCNE1
was kindly provided by Dr. Steve Goldstein (Chicago, USA). To
introduce the S277L mutation into KCNQ1, site-directed PCR-
mutagenesis was performed using the QuikChange Site-Directed
Mutagenesis kit (Stratagene, La Jolla, USA) as described [21], and
resulting cDNA was analysed by DNA sequence analysis.Fig. 1. Patient characteristics and identiﬁcation of the KCNQ1 S277L mutation. (A) pedigree
symbols denote deﬁnite long QT syndrome (i.e., Schwartz Score≥4 [1,23]), open symbols in
heterozygous S277L genotype; NG, not genotyped. (B) clinical evaluation of LQTS family m
signiﬁcant QTc prolongation. (E) membrane folding model of the KCNQ1 protein, indicating
as demonstrated by amino acid sequence alignments of S5 transmembrane segments of hum
KQT1-3, and select human voltage gated potassium (Kv) channels. S277 and its homolog
NM_004519, NM_004700, and NM_019842 for KCNQ1-5, NM_171709, NM_076991, and N
(hKv3.1), NM_012281 (hKv4.2).2.3. Heterologous gene expression in Xenopus laevis oocytes
Procedures for in vitro transcription and oocyte injection have
been published previously [9]. Brieﬂy, WT KCNQ1, KCNQ1 S277L, and
KCNE1 cRNAs were prepared with the mMESSAGE mMACHINE kit
(Ambion, Austin, USA) using T7 RNA polymerase. Stage V–VI
defolliculated Xenopus oocytes were injected with 46 nl of cRNA per
oocyte, and electrophysiological measurements were performed
2 days after injection. The investigation conforms to the Guide for
the Care and Use of Laboratory Animals published by the US National
Institute of Health (NIH Publication No. 85–23, revised 1996). The
European Community guidelines for the use of experimental animals
have been adhered to.
2.4. Electrophysiology and data analysis
Two-microelectrode voltage-clamp recordings from Xenopus laevis
oocytes were carried out as published previously [9]. Voltage clamp
measurements of Xenopus oocytes were performed in a solution
containing (in mM): 5 KCl, 100 NaCl, 1.5 CaCl2, 2 MgCl2, and 10 HEPES
(pH 7.4, adjusted with NaOH). Current and voltage electrodes were
ﬁlled with 3 M KCl solution. All experiments were carried out at roomof the LQTS family analysed in this study (arrow indicates the index patient). Closed
dicate unaffected family members. Circles refer to women, squares indicate men. S277L,
embers. (C, D) resting ECGs of the index patient (II.4; C) and patient III.1 (D) reveal
the location of the mutated amino acid residue, S227. Residue S277 is highly conserved,
an KCNQ family potassium channels KCNQ1-5, Caenorhabditis elegans KCNQ homologs
s are boxed. The respective GenBank accession numbers are AF000571, NM_172107,
M_064474 for KQT1-3, and NM_002234 (hKv1.5), NM_004974 (hKv2.1), NM_004976
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activation curves were ﬁt with a Boltzmann distribution: G(V)=Gmax/
(1−exp[(V1/2−V)/k]), where V is the test pulse potential, V1/2 is the
half-maximal activation potential, and k is the slope of the activation
curve.
2.5. Statistics
Data are expressed as mean±standard error of the mean (SEM).
Unpaired Student's t tests (two-tailed tests) were used to compare the
statistical signiﬁcance of the results: pb0.05 was considered statisti-
cally signiﬁcant. Multiple comparisons were performed using one-
way ANOVA. If the hypothesis of equal means could be rejected at the
0.05-level, pairwise comparisons of groups were made and the
probability values were adjusted for multiple comparisons using the
Bonferroni correction.
3. Results
3.1. Clinical analysis and genetics
The index patient (II.4; Fig. 1A) initially presentedwith a history of
recurrent syncope, ventricular tachycardia, and aborted sudden death
triggered by emotional arousal. The resting ECG with a QTc interval of
528 ms (Fig. 1B and C) led to the diagnosis of long QT syndrome. She
received an implantable cardioverter deﬁbrillator (ICD) and was
treated with ß-blockade, under which the patient continued to
display recurrent episodes of ventricular tachycardia. Prolonged QT
intervals were detected in three additional female family members
(Fig. 1A, B and D) as well. In contrast to the index patient, these
probands did not report any clinical symptoms of long QT syndrome
(Fig. 1B). In order to identify the underlying mutation, genomic DNA
from the index patient and from two additional family members was
sampled. DNA sequence analyses revealed C to T transversions at
nucleotide position 830 of all patients available for genetic assess-
ment. As a result, a conserved serine residue was replaced by leucine
at position 277 located in the S5 transmembrane segment of the
KCNQ1 ion channel polypeptide (Fig. 1E).
3.2. Electrophysiological analysis of mutant KCNQ1 S277L channels
Homomultimeric channels formed by wild type (WT) or mutant
KCNQ1 S277L subunits were functionally characterized in Xenopus
oocytes injected with the respective cRNA (23 ng each). Currents
were activated during depolarizing steps to potentials ranging from
−60 mV to +120 mV (2 s), and tail currents were recorded at
−40 mV (2 s). The holding potential was −80 mV, and pulses were
applied at a frequency of 0.2 Hz. This voltage protocol was used in all
electrophysiological measurements in this work. Tail currents
represent KCNQ1 channel activity, while outward currents during
the ﬁrst step of the voltage protocol may in part reﬂect low
endogenous Xenopus currents (compare Fig. 2A and D). Thus, tail
current amplitudes were analysed. Mean WT KCNQ1 current
amplitudes yielded 0.61±0.03 μA (n=21; Fig. 2A and E), while
virtually no tail current was detected in oocytes injected with mutant
KCNQ1 S277L cRNA (0.01±0.01 μA; n=21; Fig. 2B and E).
KCNQ1-associated long QT syndrome is inherited in an autosomal-
dominant manner, and affected individuals carry one WT and one
mutant KCNQ1 allele. Dominant inheritance might be explained
either by haploinsufﬁciency or by dominant-negative effects of
mutant subunits on their WT counterparts. To examine whether
KCNQ1 S277L subunits cause dominant-negative current suppression,
WT KCNQ1 cRNA (11.5 ng, i.e. 50% of the amount injected in Fig. 2A)
and mutant KCNQ1 S277L cRNA (11.5 ng, i.e. 50% of the amount
injected in Fig. 2B) were co-injected into oocytes, and the resulting
currents (Fig. 2C) were compared with WT KCNQ1 currents (Fig. 2A).Mean KCNQ1 current amplitudes were reduced by 88.5% to 0.07±
0.01 μA (n=21; Fig. 2C and E) compared to WT KCNQ1 currents,
indicating that dominant-negative suppression of WT KCNQ1 causes
current reduction in the absence of KCNE1 β-subunits.
3.3. KCNQ1 S277L causes dominant-negative IKs suppression
In human cardiomyocytes, the pore formingα-subunit KCNQ1 and
the ß-subunit KCNE1 form channels with characteristics largely
similar to IKs [4,5]. To determine whether the mutants exert a
dominant-negative effect in the presence of KCNE1 subunits as well,
we co-expressedWT and mutant KCNQ1 S277L subunits in equimolar
amounts. The resulting outward potassium current after injection of
WT KCNQ1 (11.5 ng) and KCNE1 (11.5 ng) cRNA displayed properties
nearly identical to those of native cardiac IKs, with mean tail current
amplitudes of 1.10±0.12 μA (n=36; Fig. 3A and F). In contrast, IKs
amplitudes of channels composed of KCNQ1 S277L (11.5 ng; 0.01±
0.01 μA; n=36; Fig. 3B and F) with KCNE1 were not signiﬁcantly
different from non-injected oocytes (0.01±0.01 μA; n=36; Fig. 3E
and F). However, co-expression of KCNE1 (11.5 ng) with a combina-
tion of KCNQ1 S277L and WT cRNA (5.75 ng each) yielded currents of
0.20±0.03 μA (n=36; Fig. 3C and F). Thus, S277L reduced IKs by
81.9% compared to WT currents (Fig. 3F). These data indicate that co-
assembly of WT KCNQ1 and mutant S277L subunits results in a
dominant-negative effect on IKs, reﬂecting a severe cellular pheno-
type. The activation I–V relationships for KCNQ1/KCNE1 currents
(Fig. 4A and B) reveal an 8.7 mV leftward shift in the half-maximal
activation voltage in the presence of KCNQ1 S277L (WT KCNQ1+
KCNE1: V1/2=82.2±1.2 mV; WT KCNQ1+KCNQ1 S277L+KNCE1:
V1/2=73.5±1.3 mV; n=15). In all other experiments in this study a
reasonable analysis of activation curves was prevented by low IKs tail
current amplitudes.
4. Discussion
A KCNQ1 point mutation was identiﬁed in German LQTS1 family,
resulting in replacement of a highly conserved serine residue located
in the S5 transmembrane region of the channel by leucine (KCNQ1
S277L; Fig. 1E). Electrophysiological characterisation revealed that
KCNQ1 S277L subunits did not produce functional potassium
channels and suppressed WT KCNQ1 in dominant-negative manner
in the presence and in the absence of KCNE1. The half-maximal
activation curve of IKs produced by co-expression of WT KCNQ1 and
KCNQ1 S277L with KCNE1 was shifted towards more negative
potentials, indicating direct interaction of wild type and mutant
subunits. This activation shift in isolation is expected to result in
increased current amplitudes at a given membrane potential.
However, current increase was not observed owing to strong current
suppression by mutant KCNQ1.
The severe electrophysiological phenotype may be readily
explained by the location of the affected amino acid. KCNQ1mutations
in the S5-pore-S6 region of the channel generally appear to be
associated with more severe clinical presentation [22]. The serine
residue at position 277, which is located next to the extracellular
surface of the S5 segment in close proximity to the pore helix, is highly
conserved in the family of KCNQ channels and among other potassium
channels (Fig. 1E). KCNQ1 mutations replacing serine 277 are
predicted to cause changes in the pore architecture that signiﬁcantly
affect ion conductance and result in channel dysfunction. Our
experimental data revealed that replacement of S277 by leucine
prevented KCNQ1 channel function, conﬁrming the hypothesis that
this residue is essential for structural integrity and function of the
KCNQ1 pore complex. Furthermore, Gouas et al. reported KCNQ1
trafﬁcking inhibition caused by mutation of residue S276 [23]. This
suggests that a similar mechanism may contribute to the cellular
phenotype associated with the KCNQ1 S277L mutation.
Fig. 2. Currents induced by expression of KCNQ1 α-subunits in Xenopus oocytes. Representative current traces recorded from cells expressing WT KCNQ1 (A) or KCNQ1 S277L (B)
channels are displayed. (C) currents induced by co-expression of equal amounts ofWT KCNQ1 and KCNQ1 S277L subunits. (D) currents recorded from a non-injected control cell. (E)
mean peak tail current amplitudes (n=21 cells per column; ***pb0.001 compared to WT KCNQ1). For the purpose of clear presentation, currents recorded at 100 mV and 120 mV
are not displayed in panels A to D.
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of the channel exhibit an increased risk of cardiac arrhythmias
compared to patients with mutations in the C-terminus [18–20].
Furthermore, dominant-negative in vitro effects of KCNQ1 mutations
have recently been identiﬁed as an independent risk factor for more
severe clinical courses of LQTS [20]. Here, the index patient carrying
the KCNQ1 S277Lmutationwas sensitive to stress-induced ventricular
arrhythmia. She exhibited a relatively long QTc interval and a severeclinical phenotype (recurrent syncope and tachycardia, aborted
sudden death). This corresponds well to the cellular phenotype, i.e.
inactive ion channels and dominant-negative IKs suppression. In
contrast, we identiﬁed three asymptomatic family members with
LQTS (Schwartz-Score≥4 [1,24]), indicating that genotype–pheno-
type correlations should be handled with care since IKs suppression
evaluated in heterologous expression systems may not always
correlate well with severity of the clinical phenotype [25]. This notion
Fig. 3. Expression of IKs currents. IKs was generated by co-expression of WT KCNQ1 (A) or KCNQ1 S277L (B) in combination with KCNE1 cRNA. (C) IKs currents resulting from co-
expression of KCNE1 with equal amounts of WT KCNQ1 and KCNQ1 S277L subunits. (D) currents induced by expression of KCNE1 β-subunits. (E) currents recorded from a non-
injected control cell. (F) mean peak tail current amplitudes (n=36 cells per column; ***pb0.001 compared to WT KCNQ1+KCNE1). For the purpose of clear presentation,
measurements obtained at 100 mV and 120 mV are omitted from panels A to E.
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correlation between KCNQ1 genotype and clinical phenotype
[10,15,17]. Limitations of this study arise from the fact that geneticsequencing was not performed in additional ion channel genes to
screen for second mutations after the mutation in KCNQ1 was
identiﬁed in our patients. Thus, some of the S277L mutation carriers
Fig. 4. I–V relationships for IKs peak tail currents shown in Fig. 3. (A) mean current
amplitudes. (B) normalized current amplitudes. Mean values±SEM are shown
(n=15).
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phenotype.
Mutations of KCNQ1 S277 have been reported previously (ΔS277,
S277L, S277W [19,20,26,27]). However, detailed clinical and/or
biophysical data are limited. Liu et al. [26,27] reported four S277L
mutation carriers, ofwhich two died suddenly (QTc=540 and 680 ms,
respectively) and two remained asymptomatic (QTc=470 ms in both
subjects). In contrast to the index patient reported in our study, the
affected patients died following exercise and excitement which more
frequently triggers arrhythmias in LQTS1 than emotional stress. In
summary, these clinical observations conﬁrm high phenotypic
variability associated with KCNQ1 S277 mutations.
In conclusion, theKCNQ1S277Lmutation causes longQT syndrome
1. The clinical severity of KCNQ1-associated long QT syndrome 1,
however, does not solely depend on the disease-causing mutation
itself. Rather, it appears to be determined by additional factors, such as
compound mutations, low penetrance, and the individual repolariza-
tion reserve, comprising genetic, epigenetic, hormonal, and environ-
mental factors [14,28,29,30]. In particular, the KCNE1 D85N
polymorphism was recently revealed to reduce IKs amplitudes [31].
Thus, phenotypic variabilitymaydependon the presence or absence of
KCNE1 polymorphisms in KCNQ1 S277L gene carriers.Acknowledgements
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